Symbol="BMRN"
AssetType="Common Stock"
Name="Biomarin Pharmaceutical Inc"
Description="BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California."
CIK="1048477"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="105 DIGITAL DRIVE, NOVATO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="15967724000"
EBITDA="177139000"
PERatio="236.31"
PEGRatio="0.643"
BookValue="24.84"
DividendPerShare="0"
DividendYield="0"
EPS="0.36"
RevenuePerShareTTM="11.69"
ProfitMargin="0.033"
OperatingMarginTTM="0.035"
ReturnOnAssetsTTM="0.0076"
ReturnOnEquityTTM="0.0158"
RevenueTTM="2173095000"
GrossProfitTTM="1612370000"
DilutedEPSTTM="0.36"
QuarterlyEarningsGrowthYOY="-0.58"
QuarterlyRevenueGrowthYOY="0.148"
AnalystTargetPrice="119.22"
TrailingPE="236.31"
ForwardPE="31.25"
PriceToSalesRatioTTM="10.05"
PriceToBookRatio="4.409"
EVToRevenue="9.94"
EVToEBITDA="90.91"
Beta="0.366"
num_52WeekHigh="117.77"
num_52WeekLow="80.53"
num_50DayMovingAverage="92.3"
num_200DayMovingAverage="96.42"
SharesOutstanding="187701000"
DividendDate="None"
ExDividendDate="None"
symbol="BMRN"
open="85.09"
high="87.12"
low="84.92"
price="85.52"
volume="1307040.00"
latest_trading_day="2023-07-10"
previous_close="85.07"
change="0.45"
change_percent="0.5290%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="1317283"
Change_recent_avg="-0.11"
Delta_recent_avg="2.22"
Variance_recent_avg="1.11"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="147"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0029.jpeg"
image_negative_thumbnail_id_2="1124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0157.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="685"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_professor_thumbnail_id_1="1177"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0011.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
